Navigation Links
NeuroSigma Receives Health Canada Approval for Its Monarch eTNS System for the Treatment of Drug-Resistant Epilepsy and Major Depressive Disorder
Date:5/2/2013

LOS ANGELES, May 2, 2013 /PRNewswire/ -- NeuroSigma, Inc., a California-based medical device company, today announced that it has received a Class 2 medical device license for its Monarch™ eTNS™ (external trigeminal nerve stimulation) System from Health Canada.  The license covers the use of the Monarch eTNS System for treatment of drug-resistant epilepsy (DRE), major depressive disorder (MDD), and treatment-resistant depression.

(Photo: http://photos.prnewswire.com/prnh/20130502/LA06314)

The Monarch, CE Mark approved in the European Union in 2012, but not yet approved in the United States (US), is now available to patients in Canada. Drug resistant epilepsy (DRE) is a serious medical disorder, and affects approximately 30% of all patients with epilepsy.  Major depressive disorder is a prevalent condition, affecting up to 16% of the population at some point during their lives.

The Health Canada approval was supported by years of safety and efficacy data generated in Phase I and Phase II clinical trials in the US, in which the therapy was shown to substantially reduce seizure frequency and significantly improve mood. Results from a Phase II Randomized Controlled Trial of eTNS for epilepsy were published online in the January 26, 2013 issue of Neurology®, the medical journal of the American Academy of Neurology.  The clinical trial enrolled 50 patients, and was conducted at the University of California Los Angeles (UCLA) and the
'/>"/>

SOURCE NeuroSigma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. NeuroSigma Invited to Present an Overview of eTNS for the Treatment of Epilepsy and Depression at The Royal Society of Medicine in London
2. NeuroSigma Awarded Fast Track SBIR Grant by the NIH for Development of Implantable sTNS System for Drug Resistant Epilepsy
3. NeuroSigma Announces Receipt of Notice of Allowance of U.S. Patent Application Related to External Trigeminal Nerve Stimulation (eTNS) for the Treatment of Neuropsychiatric Disorders
4. NeuroSigma Receives CE Certification
5. NeuroSigma Receives Global Quality Control Certification
6. NeuroSigma Subsidiary Acquires Thin-Film Nitinol Fabrication Patent Portfolio
7. Scioderms SD-101 Receives Breakthrough Therapy Designation from FDA for Treatment of Epidermolysis Bullosa
8. Avanir Pharmaceuticals Receives Positive CHMP Opinion for Approval of NUEDEXTA in Europe
9. drchrono Receives Investment from Box
10. InspireMD Receives Approval From US Food and Drug Administration to Begin US Regulatory Trial
11. iBio, Inc. receives Notice from NYSE MKT Staff that Company currently is not in compliance with an additional Continued Listing Standard
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... MELVILLE, N.Y. , Sept. 16, 2014 /PRNewswire/ ... ), the world,s largest provider of health care ... and medical practitioners, announced today that Stanley M. ... Officer, will participate in a healthcare services panel ... 2014.  Joining Mr. Bergman will be Dr. Stohler, ...
(Date:9/16/2014)... 16, 2014  Eli Lilly and Company (NYSE: ... an agreement to co-develop and commercialize AZD3293, an ... in development as a potential treatment for Alzheimer,s ... is characterized by the accumulation of amyloid plaque ... with the development of beta-amyloid. Inhibiting BACE is ...
(Date:9/16/2014)... , N.J. and NEW PROVIDENCE, N.J. , ... experts will present a paper on the critical elements ... oxygen storage and deliver systems at the American Society ... be held at the Chicago Sheraton Hotel and Towers ... Derrick West , program manager of Hospital ...
Breaking Medicine Technology:Henry Schein To Present At The Leerink Partners Services Roundtable 2Lilly and AstraZeneca announce alliance to co-develop potential treatment for Alzheimer's disease 2Lilly and AstraZeneca announce alliance to co-develop potential treatment for Alzheimer's disease 3Lilly and AstraZeneca announce alliance to co-develop potential treatment for Alzheimer's disease 4Linde Healthcare experts to present details on installation of medical oxygen storage and distribution systems at ASPE convention 2Linde Healthcare experts to present details on installation of medical oxygen storage and distribution systems at ASPE convention 3
... LAKE FOREST, Ill. , Jan. 22 Hospira, ... and medication delivery company, and its philanthropic arm, the Hospira Foundation, ... medical products and cash grants to support humanitarian relief efforts in ... at more than $1.5 million , are either in ...
... SOMERVILLE, N.J. , Jan. 20 ... acquisition of Acclarent, Inc., following clearance under the Hart-Scott-Rodino ... technology company dedicated to designing, developing and commercializing devices ... (ENT). Ethicon announced its agreement to acquire Acclarent ...
Cached Medicine Technology:Hospira Supports Disaster Relief Efforts in Haiti With Products and Cash Grants 2
(Date:9/16/2014)... 16, 2014 AxoGen, Inc. ... the peripheral nerve repair market, announced that it will ... Surgery of the Hand (ASSH) 2014 Annual Meeting, taking ... Center in Boston, MA. , The event, entitled “Nerve ... repair, featuring a discussion by leading nerve repair experts ...
(Date:9/16/2014)... Grants Pass, OR (PRWEB) September 16, 2014 ... PhD, is experiencing a major extended drought crisis that ... basic survival. Grigg praises the many individuals who are ... many fresh water policy solutions overlook large portion of ... creating new, possibly worse crises.     , Grigg explained his, ...
(Date:9/16/2014)... Beverly Hills, CA (PRWEB) September 16, 2014 ... to announce the launch of ACLsurgeryLA.com , a ... various ACL injuries. As an avid sports lover ... best options for treatment and recovery from injuries to ... this opportunity to offer patients a resource dedicated specifically ...
(Date:9/16/2014)... (PRWEB) September 16, 2014 Registration is ... For The Warriors®, a 10K, 5K, and 1-mile walk/run ... race is sponsored by Local 338 RWDSU/UFCW, the Town ... begin at the Town of Babylon Town Hall in ... http://www.hopeforthewarriors.org/2014LIRun . The run is organized by Hope For ...
(Date:9/16/2014)... Birmingham, Alabama (PRWEB) September 16, 2014 *To ... Birmingham, AL, visit Achieve Clinical Research on the web ( ... For those who qualify:, There is ... required , Compensation may be provided for ... stands, pneumonia and influenza are the eighth leading cause of ...
Breaking Medicine News(10 mins):Health News:AxoGen, Inc. to Host Surgeon Education Event at American Society for Surgery of the Hand 2014 Annual Meeting 2Health News:AxoGen, Inc. to Host Surgeon Education Event at American Society for Surgery of the Hand 2014 Annual Meeting 3Health News:Drought Solutions Overlook Too Many Factors Water Policy Expert Warns Sharon Kleyne 2Health News:Drought Solutions Overlook Too Many Factors Water Policy Expert Warns Sharon Kleyne 3Health News:Los Angeles Orthopedic Surgeon Spotlights ACL Conditions With New Website 2Health News:Los Angeles Orthopedic Surgeon Spotlights ACL Conditions With New Website 3Health News:The Hope For The Warriors Long Island Run For The Warriors to Honor Wounded and Families of the Fallen 2Health News:The Team at Achieve Clinical Research is Enrolling Qualified Individuals to Participate in a Pneumonia Vaccine Clinical Trial in Birmingham, Alabama 2Health News:The Team at Achieve Clinical Research is Enrolling Qualified Individuals to Participate in a Pneumonia Vaccine Clinical Trial in Birmingham, Alabama 3
... , Briefing is the second in ... , WASHINGTON, Sept. 14 The Council ... Hill titled "Translational Research - From Bench to Bedside." Health policy ... development and approval for safe and effective drugs, biologics, medical devices ...
... /PRNewswire-FirstCall/ - SXC Health Solutions Corp. ("SXC" or the ... announced it has entered into a strategic relationship with ... electronic prescribing (e-prescribing) options available to SXC,s healthcare benefits ... - health plans, employers, government agencies, pharmacy benefit managers ...
... drug therapy often doesn,t reach the right patients, study ... research suggests that the anti-breast cancer drug trastuzumab, also ... patients aren,t receiving tests that determine whether it,s appropriate ... , Under current guidelines, women with breast cancer ...
... , Desperate Housewives, Star Joins The Wellness Community ... , , PHILADELPHIA, Sept. 14 /PRNewswire-USNewswire/ ... Desperate Housewives , found himself in a role he hoped ... of his two sisters in late 2008 left Chavira shocked and ...
... , , , ... Conference(TM), an interactive forum to discuss the regulatory and operational ... trial process where improvements can be made. Scheduled for October ... lectures, interactive workshops, and panel discussions on topics that challenge ...
... , WEST PALM BEACH, Fla., Sept. ... Bootcamp University program in New York (Oct 10th) is ... for the New York program, this is a reflection ... fills. Designed for residents and fellows in core esthetic ...
Cached Medicine News:Health News:'Translational Research: From Bench to Bedside' Capitol Hill Breakfast Briefing Hosted by the Council for American Medical Innovation 2Health News:SXC Health Solutions teams with Allscripts to deliver critical prescription information to physicians at the point-of-care 2Health News:SXC Health Solutions teams with Allscripts to deliver critical prescription information to physicians at the point-of-care 3Health News:SXC Health Solutions teams with Allscripts to deliver critical prescription information to physicians at the point-of-care 4Health News:SXC Health Solutions teams with Allscripts to deliver critical prescription information to physicians at the point-of-care 5Health News:Ricardo Antonio Chavira Uses Celebrity to Support Breast Cancer Caregivers 2Health News:Ricardo Antonio Chavira Uses Celebrity to Support Breast Cancer Caregivers 3Health News:Ricardo Antonio Chavira Uses Celebrity to Support Breast Cancer Caregivers 4Health News:NCCN Holds Oncology Research Best Practices Conference 2Health News:NCCN Holds Oncology Research Best Practices Conference 3
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 8.0 mm and length 8 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 9.0 mm and length 10 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 19.0 mm and length 21 mm....
... The BacT/Alert 3D Signature is ... microbial detection system that integrates blood, ... It is a powerful microbiology workstation ... for higher volume identification and where ...
Medicine Products: